Amy Schneider

2.9k total citations · 1 hit paper
29 papers, 1.8k citations indexed

About

Amy Schneider is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Amy Schneider has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Amy Schneider's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Economic and Financial Impacts of Cancer (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Amy Schneider is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Economic and Financial Impacts of Cancer (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Amy Schneider collaborates with scholars based in United States, Slovakia and United Kingdom. Amy Schneider's co-authors include Scott K. Fridkin, Jean B. Patel, Alex Kallen, Dawn Sievert, Arjun Srinivasan, Jonathan R. Edwards, Brandi Limbago, Philip Ricks, Joseph M. Patti and Meina Liang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Amy Schneider

27 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

2012 1.2k citations Dawn Sievert, Philip Ricks et al. Infection Control and Hospital Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Schneider United States	12	635	471	467	422	313	29	1.8k
Axel Kola Germany	24	436 0.7×	929 2.0×	338 0.7×	463 1.1×	270 0.9×	66	2.0k
Rosy Reynolds United Kingdom	24	611 1.0×	539 1.1×	279 0.6×	609 1.4×	471 1.5×	62	2.1k
Cédric Jacqueline France	27	704 1.1×	319 0.7×	447 1.0×	488 1.2×	292 0.9×	74	2.0k
Yoshitomo Morinaga Japan	24	985 1.6×	314 0.7×	438 0.9×	901 2.1×	184 0.6×	171	2.2k
Chen‐Hsiang Lee Taiwan	29	777 1.2×	514 1.1×	223 0.5×	790 1.9×	127 0.4×	145	2.5k
Miki Nagao Japan	31	945 1.5×	780 1.7×	453 1.0×	1.1k 2.5×	358 1.1×	165	2.8k
Felicia Ruffin United States	22	692 1.1×	258 0.5×	255 0.5×	448 1.1×	447 1.4×	71	1.4k
F. Jacobs Belgium	26	1.1k 1.7×	510 1.1×	426 0.9×	1.2k 2.9×	175 0.6×	62	2.5k
Kenneth Rolston United States	25	957 1.5×	577 1.2×	337 0.7×	1.3k 3.0×	649 2.1×	57	3.0k
Jin‐Hong Yoo South Korea	27	826 1.3×	317 0.7×	245 0.5×	830 2.0×	300 1.0×	110	1.9k

Countries citing papers authored by Amy Schneider

Since Specialization

Citations

This map shows the geographic impact of Amy Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Schneider more than expected).

Fields of papers citing papers by Amy Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Schneider. The network helps show where Amy Schneider may publish in the future.

Co-authorship network of co-authors of Amy Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Schneider. A scholar is included among the top collaborators of Amy Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Schneider. Amy Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suidan, R.S., Charlotte C. Sun, Amy Schneider, et al.. (2024). Determination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecologic Oncology. 185. 101–107.

Sidey‐Gibbons, Chris, Charlotte C. Sun, Amy Schneider, et al.. (2022). Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data. Scientific Reports. 12(1). 21269–21269. 13 indexed citations

Sidey‐Gibbons, Chris, Charlotte C. Sun, Cai Xu, et al.. (2021). Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.. Journal of Clinical Oncology. 39(15_suppl). e13555–e13555. 1 indexed citations

Meyer, Larissa A., Amy Schneider, Samantha Williams, et al.. (2021). A qualitative exploration of the impact of ovarian cancer on the well-being of women: evaluating the intersection and influences of social determinants of health. Gynecologic Oncology. 162. S78–S79. 2 indexed citations

Liang, Meina, Bing Wang, Amy Schneider, Inna Vainshtein, & Lorin Roskos. (2020). A Novel Pharmacodynamic Biomarker and Mechanistic Modeling Facilitate the Development of Tovetumab, a Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor Alpha, for Cancer Therapy. The AAPS Journal. 23(1). 4–4. 4 indexed citations

Schneider, Amy, Inna Vainshtein, Lorin Roskos, et al.. (2016). An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox. Journal of Immunological Methods. 435. 68–76. 9 indexed citations

Liang, Meina, Martin Schwickart, Amy Schneider, et al.. (2015). Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development. Cytometry Part B Clinical Cytometry. 90(2). 117–127. 36 indexed citations

Finco, Deborah, Christine Grimaldi, Madeline Fort, et al.. (2014). Cytokine release assays: Current practices and future directions. Cytokine. 66(2). 143–155. 64 indexed citations

Soyemi, Kenneth, Andrew Medina‐Marino, Ronda L. Sinkowitz‐Cochran, et al.. (2014). Disparities among 2009 Pandemic Influenza A (H1N1) Hospital Admissions: A Mixed Methods Analysis – Illinois, April–December 2009. PLoS ONE. 9(4). e84380–e84380. 16 indexed citations

10.

Fairman, David, Rajesh Narwal, Meina Liang, et al.. (2014). Pharmacokinetics of MEDI4736, a fully human anti-PDL1 monoclonal antibody, in patients with advanced solid tumors.. Journal of Clinical Oncology. 32(15_suppl). 2602–2602. 21 indexed citations

11.

Schwickart, Martin, Jennifer Pearson, Carlos Chávez, et al.. (2013). Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay. Journal of Immunological Methods. 403(1-2). 52–61. 9 indexed citations

12.

Forero, Andres, Mehdi Hamadani, Thomas J. Kipps, et al.. (2013). Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. Journal for ImmunoTherapy of Cancer. 1(S1). 3 indexed citations

13.

Wang, Bing, Meina Liang, Zhenling Yao, et al.. (2012). Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 102(1). 250–261. 8 indexed citations

14.

Schneider, Amy, et al.. (2012). Public Perceptions and Preferences for Patient Notification After an Unsafe Injection. Journal of Patient Safety. 9(1). 8–12. 2 indexed citations

15.

MacCannell, Taranisia, Alicia Shugart, Amy Schneider, et al.. (2012). A Qualitative Assessment of a Performance Measure for Reporting Influenza Vaccination Rates among Healthcare Personnel. Infection Control and Hospital Epidemiology. 33(9). 945–948. 5 indexed citations

16.

Sievert, Dawn, Philip Ricks, Jonathan R. Edwards, et al.. (2012). Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control and Hospital Epidemiology. 34(1). 1–14. 1229 indexed citations breakdown →

17.

Ellingson, Katherine, Philip M. Polgreen, Amy Schneider, et al.. (2011). Healthcare Personnel Perceptions of Hand Hygiene Monitoring Technology. Infection Control and Hospital Epidemiology. 32(11). 1091–1096. 48 indexed citations

18.

Wise, Matthew E., Stephen G. Weber, Amy Schneider, et al.. (2011). Hospital Staff Perceptions of a Legislative Mandate for Methicillin-Resistant Staphylococcus aureus Screening. Infection Control and Hospital Epidemiology. 32(6). 573–578. 7 indexed citations

19.

Symerský, J., Joseph M. Patti, Mike Carson, et al.. (1997). Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nature Structural Biology. 4(10). 833–838. 124 indexed citations

20.

Patti, Joseph M., et al.. (1995). Isolation and characterization of pcp, a gene encoding a pyrrolidone carboxyl peptidase in Staphylococcus aureus. Gene. 166(1). 95–99. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact